Because Knetbooks knows college students. Our rental program is designed to save you time and money. Whether you need a textbook for a semester, quarter or even a summer session, we have an option for you. Simply select a rental period, enter your information and your book will be on its way!
| Preface | p. xv |
| Introduction | p. xvii |
| Cancer and Cancer Treatment Basics | |
| What Is Cancer and How Is It Treated? | p. 3 |
| What Is Cancer? | p. 3 |
| The Six Hallmarks of Cancer | p. 4 |
| The Three Mainstays of Cancer Treatment | p. 5 |
| Surgery | p. 6 |
| Radiation Therapy | p. 8 |
| Medical Therapy (Medications) | p. 9 |
| E... MORE | p. 14 |
| The Bottom Line | p. 17 |
| What Are Clinical Trials and How Are They Organized? | |
| What Is a Clinical Trial? | p. 21 |
| A Brief History of Clinical Trials | p. 21 |
| Dr. Lind's Plan | p. 22 |
| Modern Medicine | p. 22 |
| The Key Ingredients of a Clinical Trial | p. 23 |
| Clinical Trials Versus Standard Care | p. 25 |
| The Eligibility Checklist Process | p. 26 |
| Informed Consent | p. 27 |
| Information About You | p. 28 |
| Statistics in Clinical Trials | p. 28 |
| What Is Risk Reduction? | p. 29 |
| What Is a Survival Benefit? | p. 31 |
| What Does "Significant" Mean? | p. 32 |
| The Bottom Line | p. 34 |
| The Types of Clinical Trials: Four Phases and More | p. 35 |
| Phase I: Safety Testing | p. 36 |
| Blood Level Studies | p. 37 |
| Variations of Phase I Testing | p. 38 |
| The Biologically Effective Dose | p. 39 |
| Why Would You Want to Participate in a Phase I Study? | p. 40 |
| Phase II: Initial Efficacy Testing: Does the New Drug Work? | p. 40 |
| Types of Phase II Studies | p. 41 |
| What's in a Phase II Study for You? | p. 41 |
| Phase III Trials: The New Treatment Compared to Standard Care | p. 42 |
| Why Would You Volunteer for a Phase III Clinical Trial? | p. 43 |
| Phase IV Studies | p. 44 |
| What's in a Phase TV Study for You? | p. 44 |
| Phase 0 (Zero) Studies | p. 45 |
| A Word About Other Types of Studies | p. 45 |
| Why Would You Consider Participating in a Clinical Trial That Doesn't Involve a Treatment Intended to Directly Treat Cancer? | p. 46 |
| The Bottom Line: The Advantages and Disadvantages of Various Types of Clinical Trials | p. 46 |
| Randomized Trials and Placebos | p. 49 |
| Randomization: Letting the Computer Decide | p. 49 |
| Randomization in Today's Clinical Trials | p. 50 |
| Comparing Active Treatment to No Treatment | p. 51 |
| Blinding and Placebos | p. 52 |
| Benefits Can Be Hard to See Without Blinding | p. 54 |
| The Appropriate Role of Placebos in Clinical Trials | p. 55 |
| The Placebo Effect | p. 56 |
| Placebos in History | p. 57 |
| Why Are Randomized Trials So Large? | p. 58 |
| What Happens If a Study Shows a Benefit Even Before It Is Finished? | p. 58 |
| Did I Get the Best Treatment? | p. 59 |
| How Can I Be Sure I Get the New Treatment? | p. 60 |
| The Bottom Line | p. 62 |
| Clinical Trials That Have Changed Cancer Care | p. 65 |
| Surgery Cures More Women with Breast Cancer When Supported by Chemotherapy | p. 66 |
| When Less May Be More | p. 67 |
| Does Surgery Really Help Men with Prostate Cancer? | p. 68 |
| A Sum That Is Truly Better Than Its Parts: Combining Chemotherapy Drugs | p. 68 |
| Location, Location, Location | p. 69 |
| A Successful Revolution: Targeting Mutations That Cause Cancer | p. 70 |
| Hormones and Cancer Prevention | p. 71 |
| Boost Your Immune System | p. 72 |
| Debunking a Medical Bias | p. 73 |
| When Our Basic Beliefs Are Challenged | p. 74 |
| The Next Breakthrough Study-What Will it Be? | p. 75 |
| The Bottom Line | p. 75 |
| Deciding Whether to Participate in a Clinical Trial | |
| Is There a Clinical Trial That's Right for Me? | p. 79 |
| Deciding Whether to Participate in a Clinical Trial | p. 79 |
| What Should You Know Before Choosing a Clinical Trial? | p. 80 |
| What Potential Benefits and Risks Should You Consider Before Choosing a Clinical Trial? | p. 80 |
| The Effects of Attitudes, Emotions, and Reality in Choosing a Clinical Trial | p. 81 |
| "I Just Want to Be Left Alone!" | p. 82 |
| Cancer Support Groups | p. 83 |
| Choosing the Right Trial for Your Needs | p. 84 |
| I'm Interested. What Do I Do Next? | p. 84 |
| Start Close to Home | p. 85 |
| Know Your Disease State, Stage, and Prior and Current Treatments | p. 85 |
| Searching Online-The Basics | p. 86 |
| Advanced Searches | p. 88 |
| I've Done My Homework…Now What? | p. 90 |
| The Bottom Line | p. 92 |
| Who Is Looking Out for You and What Can You Expect? | p. 93 |
| How Are Studies Overseen and Regulated? | p. 93 |
| The Power of the FDA | p. 94 |
| Not One, but Two Animal Tests! | p. 95 |
| Truly Independent, Ail-Powerful Oversight: The Data Safely Monitoring Board | p. 95 |
| What Can I Expect From My Doctor and Investigative Team? | p. 97 |
| What If I Have Concerns and I'm Not Sure Where to Go for an Answer? | p. 98 |
| Am I Free to Quit If I Want To? | p. 98 |
| What If I Have Side Effects? How Will I Know If I Should Be Concerned? | p. 99 |
| What If Something Goes Wrong? | p. 100 |
| How Do You Get Through the Red Tape? | p. 100 |
| Why Are There Delays? | p. 101 |
| A Concern You May Have: "If I Start a Clinical Trial, and the Trial Medications Don't Work, I Could Be Wasting Valuable Time." | p. 102 |
| The Bottom Line | p. 105 |
| Who Pays for Clinical Trials-And What Can They Cost? | p. 107 |
| What Costs Are Involved in Clinical Trials? | p. 108 |
| Who Pays for These Costs? | p. 108 |
| Costs of Your Care and Insurance Coverage of Cancer Clinical Trials | p. 109 |
| Medicare Comes Through | p. 111 |
| Traditional Health Insurance | p. 114 |
| The Bottom Line | p. 121 |
| Medical Treatment of Cancer Now, and in the Future | |
| Cancer Drugs Currently in Use and Being Tested in Trials | p. 125 |
| Chemotherapy Drugs | p. 125 |
| Antimetabolites | p. 127 |
| Alkylating Agents | p. 128 |
| DNA Cross-Linking Platinum Derivatives | p. 128 |
| Antitumor Antibiotics | p. 129 |
| Topoisomerase Inhibitors | p. 129 |
| Microtubule Assembly and Disassembly Inhibitors (Mitotic Inhibitors) | p. 129 |
| Hormonal Agents | p. 130 |
| Testosterone- and Estrogen-Lowering Drugs | p. 130 |
| Hormone-Blocking Drugs | p. 131 |
| Testosterone Conversion/Activation Blockers | p. 132 |
| Small-Molecule Targeted Drugs | p. 132 |
| Monoclonal Antibodies | p. 134 |
| Immunotherapy | p. 134 |
| Differentiation Therapy | p. 135 |
| Gene Therapy | p. 136 |
| A Last Word About Drugs | p. 136 |
| The Bottom Line | p. 137 |
| The Future of Cancer Treatment and Clinical Trials: Personalized Medicine | p. 139 |
| Targeted Therapy | p. 139 |
| Personalized Therapy | p. 140 |
| Pharmacogenomics | p. 142 |
| The Bottom Line | p. 142 |
| A Final Word | p. 144 |
| Tell Us What You Think | p. 144 |
| Glossary | p. 145 |
| Resources | p. 155 |
| General Clinical Trials Information | p. 155 |
| Information Specific by Tumor Type | p. 156 |
| Index | p. 157 |
| Table of Contents provided by Ingram. All Rights Reserved. |